CompletedPhase 2NCT03546621

A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis D

Studying Hepatitis delta

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Hepatera Ltd.
Principal Investigator: Heiner Wedemeyer, MD,PhD
Dept. of Gastroenterology, Hepatology and Endocrinology Medizinische Hochschule Hannover
Intervention: Myrcludex B(drug)
Enrollment: 120 target
Eligibility: 18-65 years · All sexes
Timeline: 2016 – 2018

Study locations (15)

Ifi-Institut für interdisziplinäre Medizin an der Asklepios Klinik St. Georg, Hamburg, Germany
Universitätsklinikum Hamburg-Eppendorf Medizinische Klinik Studienambulanz Hepatologie, Hamburg, Germany
Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover, Hanover, Germany
UniversitätsKlinikum Heidelberg - Medizinische Klinik, Abteilung Klinische Pharmakologie & Pharmakoepidemiologie, Heidelberg, Germany
State Budgetary educational institution of higher professional education "South Ural State Medical University" Ministry of healthcare, Chelyabinsk, Russia
State Autonomous Healthcare Institution "Republican Clinical Infectious Diseases Hospital named after Prof. A.F. Agafonov "(SAHI RCID), Kazan', Russia
Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance, Moscow, Russia
LLC "Clinic of Modern Medicine", Moscow, Russia
Moscow Regional Research Clinical Institute n.a. M.F. Vladimirskiy, Moscow, Russia
State Budget Health Institution of Moscow "Infectious Clinical Hospital No. 1 of the Moscow Healthcare Department", Moscow, Russia
State Budgetary Healthcare Institution "Moscow Clinical Scientific and Practical Center of the Department of Public Health of Moscow", Moscow, Russia
State Budgetary Educational Institution of Higher Professional Education "Novosibirsk State Medical University" of the Ministry of Health of the Russian Federation, Novosibirsk, Russia
Medical Company "Hepatolog", Samara, Russia
Stavropol Regional Clinical Hospital, Stavropol, Russia
State Budgetary institution of the Republic of Sakha (Yakutia) "Yakutsk Clinical Hospital", Yakutsk, Russia

Collaborators

Data Matrix Solutions

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03546621 on ClinicalTrials.gov

Other trials for Hepatitis delta

Additional recruiting or active studies for the same condition.

See all trials for Hepatitis delta →

← Back to all trials